Cisplatin Micelle Injection (HA132)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Cisplatin Micelle Injection (HA132), covering 2022-07-29 to 2022-07-29. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Antitumor Efficacy of Cisplatin Micelle Injection (HA132) in Patients With Advanced Malignant Solid Tumors [Phase 1, Phase 2]